Envoy Medical Submits First Module Of Modular Premarket Approval Application To FDA For Breakthrough Device-Designated Product; Co Plans Fou
Modular Regulatory Strategy Creates Defined Milestone Cadence, Enables Earlier FDA Engagement, and Supports Targeted Final Clinical Module Submission Planned for Q2 2027 White Bear Lake, Minnesota--(Newsfile Corp. - June 30, 2026) - Envoy Medical ® Inc. (NASDAQ: COCH ) ("Envoy Medical" or the "Company"), a hearing heal